A FORMER tax consultant and auditor with PwC has been appointed as chief financial officer of pharmaceutical company Patheon.
Stuart Grant joins from BioCryst Pharmaceuticals where he was CFO having previously served as CFO for Serono until the company was acquired.
Patheon provides development and manufacturing services to the pharmaceutical industry.
CFO Kirk Davis talks to Financial Director about the challenge of unlocking the financial potential of Greene King's £774m acquisition of the Spirit Pub Company in 2015
FTSE 250 company Wood Group has appointed a new chief financial officer for its specialist technical solutions business
“The next generation of competitors will come up like mushrooms during the night.” Dr. Stephan Hardt talks about cyber, new technology and the changing role of the CFO
OakNorth Bank, the specialists in lending money to growth businesses, has appointed a new CFO from GE Capital Finance